Enveric Biosciences, Inc.
ENVB
Rank in Stocks
#29905
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Share Price
$1.44
Last synced: 2026-11-09
Market Cap
$6.45M
Change (1 day)
1.12%
Change (1 year)
-75.92%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Enveric Biosciences, Inc. (ENVB)
Category
Healthcare
Dividend history for Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (stock symbol: ENVB) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $15.75K
Dividend yield (TTM) : 0.00%
The sum of all dividends (adjusted for stock splits) is : $15.75K
Dividend yield (TTM) : 0.00%
Dividend payments for Enveric Biosciences, Inc. (ENVB) from 2008 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $15,749.92 | 0.00% |
| 2008 | $15,749.92 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.021 | 0.00% |
| 2008 | $0.021 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
